LICENSE AGREEMENT BETWEENLicense Agreement • August 9th, 2016 • Adverum Biotechnologies, Inc. • Biological products, (no disgnostic substances) • New York
This agreement ("Agreement") is made by and between Annapurna Therapeutics Limited, an Irish corporation having an address at 9 Upper Pembroke Street, Dublin 2 ("LICENSEE") and Cornell University (“Cornell”) as represented by its Center for Technology Licensing ("CTL") at Cornell University at 395 Pine Tree Road, Ithaca, NY 14850.
License AgreementLicense Agreement • August 9th, 2016 • Adverum Biotechnologies, Inc. • Biological products, (no disgnostic substances) • New York
This LICENSE AGREEMENT (“Agreement”) is entered into as of October 20, 2015 (“Effective Date”) by and between REGENXBIO Inc., a corporation organized under the laws of the State of Delaware, with offices at 9712 Medical Center Drive, Suite 100, Rockville, MD 20850, USA (“Licensor”), and Annapurna Therapeutics Limited organized under the laws of Ireland, with offices at 14 Taney Hall, Eglinton Terrace, Dundrum Dublin D14 C7F7, Ireland (“Licensee”). Licensor and Licensee are hereinafter referred to individually as a “Party” and collectively as the “Parties.”
Amended and Restated Master Services AgreementMaster Services Agreement • August 9th, 2016 • Adverum Biotechnologies, Inc. • Biological products, (no disgnostic substances) • New York
This Amended and Restated Master Services Agreement (together with its Schedules, this “Agreement”) is made effective from July 15 2014 (the “Effective Date”) and amends and restates in its entirety that certain Master Services Agreement effective July 15th, 2014 between Annapurna Therapeutics, SAS (formerly AAVLife), a French simplified joint stock company (societe par actions simplifiee) (“Annapurna”), and Cornell University, for and on behalf of its Joan and Sanford I. Weill Medical College, a New York education corporation (“Cornell”). Each of Annapurna and Cornell may be referred to herein as a “Party” or, collectively, as the “Parties.”
ContractLicense Agreement • August 9th, 2016 • Adverum Biotechnologies, Inc. • Biological products, (no disgnostic substances)
[***] Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions.
LICENSE AGREEMENTLicense Agreement • August 9th, 2016 • Adverum Biotechnologies, Inc. • Biological products, (no disgnostic substances) • New York
This LICENSE AGREEMENT (“Agreement”) is entered into as of April 10, 2014 (“Effective Date”) by and between ReGenX Biosciences, LLC, a limited liability company organized under the laws of the State of Delaware, with offices at 750 17th Street, NW, Suite 1100, Washington, DC 20006, USA (“Licensor”), and AAVLife, a French simplified joint stock company (Société par actions simplifiée) whose registered office is 183/189 avenue de Choisy — 75013 Paris, France (“Licensee”). Licensor and Licensee are hereinafter referred to individually as a “Party” and collectively as the “Parties.”
LICENSE AGREEMENTLicense Agreement • August 9th, 2016 • Adverum Biotechnologies, Inc. • Biological products, (no disgnostic substances)
THIS LICENSE AGREEMENT (the “Agreement”) is made and entered into effective as of July 4, 2014 (the “Effective Date”) by and between Inserm Transfert, a limited company organized under the laws of France, whose registered headquarters are located at 7 rue Watt, 75013 PARIS, France, N° SIRET 434 033 619 00025, co de APE 7219Z, RCS Paris B 434 033 619, represented by its Chairman of the Board of Management, Mrs. Pascale AUGE (“Inserm Transfert”), acting as delegatee of Institut National de la Santé Et de la Recherche Médicale (“Inserm”), French National Institute of Health and Medical Research, a public scientific and technological establishment having its principal offices at 101 rue de Tolbiac, 75654 Paris Cedex 13, France, as part of the activities of lnserm Unit U964 “INSTITUTE OF GENETICS AND MOLECULAR AND CELLULAR BIOLOGY,” directed by Brigitte KIEFFER located at Parc d’Innovation - 1 rue Laurent Fries - 67404 Illkirch Cedex France, and of lnserm Unit U986 “GENOMICS, ENVIRONMENT FA
